
Sign up to save your podcasts
Or


Abbott Labs hits a new all-time high after the FDA approves the company’s rapid Covid-19 test. Tiffany and Dollar General issue 2nd-quarter reports, offering an interesting look at both ends of the retail spectrum. Jim Gillies analyzes those stories, and shares some compelling reasons why investors looking for steady yield should take a closer look at the “Big Five” banks in Canada.
By The Motley Fool4.7
16041,604 ratings
Abbott Labs hits a new all-time high after the FDA approves the company’s rapid Covid-19 test. Tiffany and Dollar General issue 2nd-quarter reports, offering an interesting look at both ends of the retail spectrum. Jim Gillies analyzes those stories, and shares some compelling reasons why investors looking for steady yield should take a closer look at the “Big Five” banks in Canada.

3,228 Listeners

1,498 Listeners

807 Listeners

938 Listeners

518 Listeners

1,173 Listeners

2,175 Listeners

825 Listeners

1,416 Listeners

1,044 Listeners

9,722 Listeners

196 Listeners

828 Listeners

82 Listeners

597 Listeners

989 Listeners

53 Listeners